These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 3698943)

  • 1. Comparison of multiple parameters of rodent carcinogenicity and in vitro genetic toxicity.
    Tennant RW; Stasiewicz S; Spalding JW
    Environ Mutagen; 1986; 8(2):205-27. PubMed ID: 3698943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens II. Further analysis of mammalian cell results, relative predictivity and tumour profiles.
    Kirkland D; Aardema M; Müller L; Makoto H
    Mutat Res; 2006 Sep; 608(1):29-42. PubMed ID: 16769241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemicals associated with site-specific neoplasia in 1394 long-term carcinogenesis experiments in laboratory rodents.
    Huff J; Cirvello J; Haseman J; Bucher J
    Environ Health Perspect; 1991 Jun; 93():247-70. PubMed ID: 1773796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of carcinogenicity from two versus four sex-species groups in the carcinogenic potency database.
    Gold LS; Slone TH
    J Toxicol Environ Health; 1993 May; 39(1):143-57. PubMed ID: 8492327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity.
    Kirkland D; Aardema M; Henderson L; Müller L
    Mutat Res; 2005 Jul; 584(1-2):1-256. PubMed ID: 15979392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictions for the outcome of rodent carcinogenicity bioassays: identification of trans-species carcinogens and noncarcinogens.
    Tennant RW; Spalding J
    Environ Health Perspect; 1996 Oct; 104 Suppl 5(Suppl 5):1095-100. PubMed ID: 8933059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carcinogenicity of mutagens: predictive capability of the Salmonella mutagenesis assay for rodent carcinogenicity.
    Zeiger E
    Cancer Res; 1987 Mar; 47(5):1287-96. PubMed ID: 3815340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The results of assays in Drosophila as indicators of exposure to carcinogens.
    Vogel EW; Graf U; Frei HJ; Nivard MM
    IARC Sci Publ; 1999; (146):427-70. PubMed ID: 10353398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
    Gaylor DW
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carcinogenicity results for 114 laboratory animal studies used to assess the predictivity of four in vitro genetic toxicity assays for rodent carcinogenicity.
    Haseman JK; Clark AM
    Environ Mol Mutagen; 1990; 16 Suppl 18():15-31. PubMed ID: 2091922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationships between in vitro genetic toxicity and carcinogenicity studies in animals.
    Tennant RW
    Ann N Y Acad Sci; 1988; 534():127-32. PubMed ID: 3291706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between carcinogenic potency and tumor pathology in rodent carcinogenesis bioassays.
    Gold LS; Ward JM; Bernstein L; Stern B
    Fundam Appl Toxicol; 1986 May; 6(4):677-90. PubMed ID: 3710036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stratification of rodent carcinogenicity bioassay results to reflect relative human hazard.
    Tennant RW
    Mutat Res; 1993 Mar; 286(1):111-8. PubMed ID: 7678907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mouse-specific carcinogens: an assessment of hazard and significance for validation of short-term carcinogenicity bioassays in transgenic mice.
    Battershill JM; Fielder RJ
    Hum Exp Toxicol; 1998 Apr; 17(4):193-205. PubMed ID: 9617631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal mouse assay for tumorigenicity: alternative to the chronic rodent bioassay.
    Flammang TJ; Tungeln LS; Kadlubar FF; Fu PP
    Regul Toxicol Pharmacol; 1997 Oct; 26(2):230-40. PubMed ID: 9356286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of target organs of carcinogenicity for mutagenic and non-mutagenic chemicals.
    Gold LS; Slone TH; Stern BR; Bernstein L
    Mutat Res; 1993 Mar; 286(1):75-100. PubMed ID: 7678909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical structure, Salmonella mutagenicity and extent of carcinogenicity as indicators of genotoxic carcinogenesis among 222 chemicals tested in rodents by the U.S. NCI/NTP.
    Ashby J; Tennant RW
    Mutat Res; 1988 Jan; 204(1):17-115. PubMed ID: 3277047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of rodent carcinogenicity for 44 chemicals: results.
    Ashby J; Tennant RW
    Mutagenesis; 1994 Jan; 9(1):7-15. PubMed ID: 8208133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemicals classified by IARC: their potency in tests for carcinogenicity in rodents and their genotoxicity and acute toxicity.
    McGregor DB
    IARC Sci Publ; 1992; (116):323-52. PubMed ID: 1428089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of toxicity on carcinogenicity studies: implications for risk assessment.
    Hoel DG; Haseman JK; Hogan MD; Huff J; McConnell EE
    Carcinogenesis; 1988 Nov; 9(11):2045-52. PubMed ID: 3052903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.